Big News Alert: Theriva Biologics Pulls a Reverse Stock Split – What Does That Even Mean?!

Welcome to Theriva Biologics, Inc.’s Reverse Stock Split Extravaganza! What’s the Buzz About? Well folks, Theriva Biologics, Inc. (NYSE American: TOVX) just dropped a bombshell by announcing a reverse stock split of its common stock. That’s right, they’re shaking things up in the financial world by consolidating their shares at a ratio of 1 share…

Read More

Unlocking the Potential of Avalanche: AVAX Price Holds Strong Above $40, Set to Reach $60 with a 50% Reversal

The Avalanche Price Soars to New Heights Breaking Past Resistance It’s been an exciting time for Avalanche (AVAX) investors as the price has surged to retest the $45 mark, with eyes set on hitting $50. The cryptocurrency market has been buzzing with the news of AVAX’s impressive performance, especially considering the challenges faced by other…

Read More

Trevi Therapeutics Presents New Findings on Cough Relief in PH2A Canal Trial at CHEST 2024

A New Breakthrough in Cough Relief: Analysis of Nalbuphine ER Treatment in Idiopathic Pulmonary Fibrosis Patients Introduction Professor Alyn Morice will present an analysis of cough relief in patients with idiopathic pulmonary fibrosis who were treated with nalbuphine ER. Trevi Therapeutics, Inc. has announced that data from the Phase 2a CANAL trial will be presented…

Read More

Discovering the Truth: My Experience with Light Wonder Inc. (LNW) – A Call to Action for Investors

Levi & Korsinsky Investigates Light & Wonder, Inc. for Possible Securities Law Violations An In-Depth Look Into the Allegations Recently, Levi & Korsinsky announced that they have launched an investigation into Light & Wonder, Inc. for potential violations of federal securities laws. This news has sent shockwaves through the investment community, as investors scramble to…

Read More